Smiths Group (LON:SMIN) had its price objective hoisted by investment analysts at Royal Bank of Canada from GBX 1,300 ($16.00) to GBX 1,530 ($18.83) in a note issued to investors on Tuesday, Stock Target Advisor reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s price target indicates a potential upside of 0.76% from the stock’s previous close.
A number of other research firms have also recently weighed in on SMIN. Citigroup reaffirmed a “buy” rating on shares of Smiths Group in a research report on Tuesday, April 7th. JPMorgan Chase & Co. lifted their price objective on Smiths Group from GBX 1,300 ($16.00) to GBX 1,500 ($18.46) and gave the company an “overweight” rating in a research report on Wednesday, July 1st. Morgan Stanley boosted their price target on Smiths Group from GBX 1,370 ($16.86) to GBX 1,490 ($18.34) and gave the stock an “equal weight” rating in a report on Wednesday, July 1st. Barclays boosted their price target on Smiths Group from GBX 1,375 ($16.92) to GBX 1,690 ($20.80) and gave the stock an “overweight” rating in a report on Monday, July 6th. Finally, Societe Generale lowered their price target on Smiths Group from GBX 1,450 ($17.84) to GBX 1,435 ($17.66) and set a “hold” rating on the stock in a report on Friday, July 3rd. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Smiths Group currently has a consensus rating of “Buy” and a consensus target price of GBX 1,560.71 ($19.21).
SMIN stock opened at GBX 1,518.50 ($18.69) on Tuesday. Smiths Group has a twelve month low of GBX 790 ($9.72) and a twelve month high of GBX 2,246.40 ($27.64). The company has a quick ratio of 0.92, a current ratio of 2.76 and a debt-to-equity ratio of 66.83. The stock has a market cap of $6.02 billion and a P/E ratio of 24.18. The business’s 50-day moving average price is GBX 1,346.46 and its 200-day moving average price is GBX 1,400.74.
Smiths Group Company Profile
Smiths Group plc operates as a technology company severing the medical technology, security and defense, general industrial, oil and gas, and space and commercial aerospace markets worldwide. The company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, and Flex-Tek.
Further Reading: How a Strangle Strategy is different from a Straddle Strategy
Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with MarketBeat.com's FREE daily email newsletter.